NHI vs GMRE

For growth investors, National Health Investors, Inc.

(NHI) is the stronger pick with 12. 9% revenue growth year-over-year, versus -1. 8% for Global Medical REIT Inc. (GMRE). National Health Investors, Inc. (NHI) offers the better valuation at 24. 2x trailing P/E (21. 6x forward), making it the more compelling value choice. Analysts rate Global Medical REIT Inc. (GMRE) a "Buy" — based on 22 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, National Health Investors, Inc.

(NHI) is the cheapest at 24. 2x versus Global Medical REIT Inc. at 115. 3x. On forward P/E, National Health Investors, Inc. is actually cheaper at 21. 6x.

Over the past 5 years, National Health Investors, Inc.

(NHI) delivered a total return of +30. 0%, compared to -19. 7% for Global Medical REIT Inc. (GMRE). Over 10 years, the gap is even starker: GMRE returned +308. 1% versus NHI's +59. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), National Health Investors, Inc.

(NHI) is the lower-risk stock at -0. 08β versus Global Medical REIT Inc. 's 0. 48β — meaning GMRE is approximately -672% more volatile than NHI relative to the S&P 500. On balance sheet safety, National Health Investors, Inc. (NHI) carries a lower debt/equity ratio of 76% versus 118% for Global Medical REIT Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), National Health Investors, Inc.

(NHI) is pulling ahead at 12. 9% versus -1. 8% for Global Medical REIT Inc. (GMRE). On earnings-per-share growth, the picture is similar: National Health Investors, Inc. grew EPS -3. 5% year-over-year, compared to -94. 6% for Global Medical REIT Inc.. Over a 3-year CAGR, NHI leads at 10. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

National Health Investors, Inc.

(NHI) is the more profitable company, earning 37. 6% net margin versus 4. 8% for Global Medical REIT Inc. — meaning it keeps 37. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NHI leads at 51. 5% versus 23. 6% for GMRE. At the gross margin level — before operating expenses — GMRE leads at 78. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, National Health Investors, Inc.

(NHI) trades at 21. 6x forward P/E versus 595. 7x for Global Medical REIT Inc. — 574. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NHI: 16. 8% to $85. 40.

All stocks in this comparison pay dividends.

Global Medical REIT Inc. (GMRE) offers the highest yield at 63. 5%, versus 4. 9% for National Health Investors, Inc. (NHI).

For long-horizon retirement investors, National Health Investors, Inc.

(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 08), 4. 9% yield). Both have compounded well over 10 years (NHI: +59. 2%, GMRE: +308. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.